Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multi-centric Castleman's Disease × tocilizumab × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 5 Multiple Myeloma 4 Recurrence 2 Melanoma 2 Lymphoma 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Solid Tumors 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Cytokine Release Syndrome 1 Craniopharyngioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Liver Cancers 1

Interventions

liposomal doxorubicin 2 pomalidomide 1 Zidovudine 1 Vincristine 1 Valganciclovir 1 Sirolimus 1 Rituximab 1 Prednisone 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡